Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Laura Kalveram"'
Autor:
Laura Kalveram, Gunnar Kleinau, Kamila Szymańska, Patrick Scheerer, Adolfo Rivero-Müller, Annette Grüters-Kieslich, Heike Biebermann
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 22, p 5564 (2019)
(1) Background: Central congenital hypothyroidism (CCH) is a rare endocrine disorder that can be caused by mutations in the β-subunit of thyrotropin (TSHB). The TSHB mutation C105Vfs114X leads to isolated thyroid-stimulating-hormone-(TSH)-deficiency
Externí odkaz:
https://doaj.org/article/98e240326f184b89b34f78bde5d32406
Autor:
Susanna Wiegand, Laura Kalveram, Jacob Gohlisch, Johanna Overberg, Peter Kühnen, Jana Brauchmann
Publikováno v:
Childhood Obesity. 17:136-143
Introduction: Obesity is a major health burden in children and adolescents. One influential factor is the choice of food, which is partly determined by gustatory perception. Cross-sectional studies...
Autor:
Susanna Wiegand, Laura Kalveram
Publikováno v:
Adipositas - Ursachen, Folgeerkrankungen, Therapie. 14:88-95
ZusammenfassungDie nicht-alkoholische Fettlebererkrankung (NAFLD) ist die häufigste chronische Lebererkrankung im Kindes- und Jugendalter und eng mit Übergewicht und Adipositas assoziiert. Es kommt zur Fetteinlagerung in die Hepatozyten – teilwei
Publikováno v:
International journal of obesity (2005). 46(5)
Background/objectives Sleeping behavior and individual prospensity in sleep timing during a 24 h period, known as chronotypes, are underestimated factors, which may favor the development of obesity and metabolic diseases. Furthermore, melatonin is kn
Autor:
Christian H. Holland, Antje Mohs, Laura Kalveram, Mona Peltzer, Thomas Longerich, Julio Saez-Rodriguez, Tobias Otto, Jan G. Hengstler, Christian Trautwein, Susanna Wiegand, Kai Markus Schneider, Christian A. Hudert, Mark V. Boekschoten
Publikováno v:
Journal of Hepatology, 74(3), 638-648
Journal of Hepatology 74 (2021) 3
Journal of Hepatology 74 (2021) 3
Background & Aims In chronic liver diseases, inflammation induces oxidative stress and thus may contribute to the progression of liver injury, fibrosis, and carcinogenesis. The KEAP1/NRF2 axis is a major regulator of cellular redox balance. In the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4616e1038dd0733eaf8ee78937b48448
https://research.wur.nl/en/publications/hepatocyte-specific-nrf2-activation-controls-fibrogenesis-and-car
https://research.wur.nl/en/publications/hepatocyte-specific-nrf2-activation-controls-fibrogenesis-and-car
Autor:
Jing Guo, Hermann-Georg Holzhütter, Ingolf Sack, Christoph Loddenkemper, Jürgen Braun, Laura Kalveram, Birgit Rudolph, Heiko Tzschätzsch, Susanna Wiegand, Christian A. Hudert
Publikováno v:
Acta biomaterialia. 123
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents. About 30% of patients with NAFLD progress to the more severe condition of nonalcoholic steatohepatitis (NASH), which is typically diagnosed
Autor:
M. Boekschoten, Julio Saez-Rodriguez, Christian H. Holland, Antje Mohs, Tobias Otto, Laura Kalveram, Susanna Wiegand, Christian A. Hudert, Christian Trautwein, Kai Markus Schneider, MT Peltzer, Jan G. Hengstler
Publikováno v:
DGVS Digital: BEST OF DGVS.
Autor:
Philip Bufler, Wolf-Hagen Schunck, Marten Schulz, Christoph Loddenkemper, Christian A. Hudert, Michael Rothe, Susanna Wiegand, Ingrid W. Zhang, Hermann-Georg Holzhütter, Laura Kalveram, Birgit Rudolph, Karsten H. Weylandt, David Meierhofer, Stephan Henning
Publikováno v:
Prostaglandins, Leukotrienes and Essential Fatty Acids. 164:102229
Non-alcoholic fatty liver disease (NAFLD) is a significant health burden in obese children for which there is currently no specific therapy. Preclinical studies indicate that epoxyeicosanoids, a class of bioactive lipid mediators that are generated b
Autor:
Lutz Schomburg, Josef Köhrle, Laura Kalveram, Annette Grüters-Kieslich, Heike Biebermann, Mariusz W. Szkudlinski, Gunnar Kleinau
Publikováno v:
Molecular Endocrinology. 30:954-964
Naturally occurring thyrotropin (TSH) mutations are rare, which is also the case for the homologous heterodimeric glycoprotein hormones (GPHs) follitropin (FSH), lutropin (LH), and choriogonadotropin (CG). Patients with TSH-inactivating mutations pre